18889881171
Alaunos Therapeutics, Inc. (NASDAQ: TCRT) a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies.
Published At: Jun 02, 2022 12:00 AM PDT
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms and Conditions
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!